NVCR CIK: 1645113

NovoCure Ltd

  • Switzerland
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
1.07
FY22:
1.11
FY23:
1.03
FY24:
1.11
FY25:
0.65
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.08
FY23:
0.11
FY24:
0.13
FY25:
0.16
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.14
FY22:
1.19
FY23:
1.15
FY24:
1.24
FY25:
0.80

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.14
FY22:
0.16
FY23:
0.18
FY24:
0.76
FY25:
0.22
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.59
FY22:
0.59
FY23:
0.60
FY24:
0.12
FY25:
0.24
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.41
FY22:
0.44
FY23:
0.36
FY24:
0.36
FY25:
0.34
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.14
FY22:
1.19
FY23:
1.15
FY24:
1.24
FY25:
0.80

All amounts in billions USD Data source:SEC EDGAR